Protein Kinase C α is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells

Author： Frankel Lisa   Lykkesfeldt Anne   Hansen Jens   Stenvang Jan  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.104, Iss.2, 2007-08, pp. : 165-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased expression of enolase α in human breast cancer confers tamoxifen resistance in human breast cancer cells

By Tu Shih-Hsin  

Breast Cancer Research and Treatment, Vol. 121, Iss. 3, 2010-06 ,pp. : 539-553

Springer Publishing Company

Access to resources Recommend Favorite

Carboplatin treatment of antiestrogen-resistant breast cancer cells

By        

International Journal of Oncology, Vol. 41, Iss. 5, 2012-01 ,pp. : 1863-1870

Spandidos Publications

Access to resources Recommend Favorite

Differential effects of protein kinase C agonists on prostaglandin production and growth in human breast cancer cells

By Boorne A.J.   Donnelly N.   Schrey M.P.  

Breast Cancer Research and Treatment, Vol. 48, Iss. 2, 1998-03 ,pp. : 117-124

Springer Publishing Company

Access to resources Recommend Favorite

Sorafenib and nilotinib resensitize tamoxifen resistant breast cancer cells to tamoxifen treatment via estrogen receptor α

By        

International Journal of Oncology, Vol. 45, Iss. 5, 2014-01 ,pp. : 2167-2175

Spandidos Publications

Access to resources Recommend Favorite

Mitogen-activated protein kinase phosphatase 1 is involved in tamoxifen resistance in MCF7 cells

By                

Oncology Reports, Vol. 34, Iss. 5, 2015-01 ,pp. : 2423-2430

Spandidos Publications

Access to resources Recommend Favorite